- Home
- MHK vs HALO Comparison
MHK vs HALO Comparison
Compare MHK & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHK
- HALO
- Stock Information
- Founded
- MHK 1988
- HALO 1998
- Country
- MHK United States
- HALO United States
- Employees
- MHK N/A
- HALO N/A
- Industry
- MHK Home Furnishings
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MHK Consumer Discretionary
- HALO Health Care
- Exchange
- MHK Nasdaq
- HALO Nasdaq
- Market Cap
- MHK 7.2B
- HALO 7.4B
- IPO Year
- MHK 1992
- HALO N/A
- Fundamental
- Price
- MHK $110.63
- HALO $53.60
- Analyst Decision
- MHK Buy
- HALO Buy
- Analyst Count
- MHK 14
- HALO 9
- Target Price
- MHK $141.64
- HALO $63.78
- AVG Volume (30 Days)
- MHK 801.7K
- HALO 2.1M
- Earning Date
- MHK 05-01-2025
- HALO 05-06-2025
- Dividend Yield
- MHK N/A
- HALO N/A
- EPS Growth
- MHK N/A
- HALO 55.40
- EPS
- MHK 7.66
- HALO 3.76
- Revenue
- MHK $10,683,300,000.00
- HALO $1,084,306,000.00
- Revenue This Year
- MHK $0.06
- HALO $20.06
- Revenue Next Year
- MHK $3.07
- HALO $24.20
- P/E Ratio
- MHK $13.88
- HALO $17.71
- Revenue Growth
- MHK N/A
- HALO 25.64
- 52 Week Low
- MHK $96.24
- HALO $41.28
- 52 Week High
- MHK $164.29
- HALO $70.51
- Technical
- Relative Strength Index (RSI)
- MHK 57.84
- HALO 60.23
- Support Level
- MHK $99.90
- HALO $58.38
- Resistance Level
- MHK $107.68
- HALO $69.94
- Average True Range (ATR)
- MHK 3.41
- HALO 2.71
- MACD
- MHK 0.78
- HALO 0.84
- Stochastic Oscillator
- MHK 76.24
- HALO 69.44
About MHK Mohawk Industries Inc.
Mohawk Industries Inc manufactures a wide range of flooring products, including carpets, rugs, ceramic tile, laminate, wood, luxury vinyl tile, and vinyl flooring. Its operating segments include Global Ceramic, Flooring North America, and Flooring Rest of the World. The company generates maximum revenue from the Global Ceramic segment. Geographically, it derives a majority of its revenue from the United States, while it also operates in Latin America, Europe and Others.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.